Literature DB >> 10757056

Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.

J M Carethers1, T T Pham.   

Abstract

Inactivation of the DNA mismatch repair (MMR) system allows the genome to accumulate mutations because of failure to correct mispairing of nucleotides and slippage mistakes at microsatellite sequences (termed microsatellite instability ¿MSI¿). While most mutations are acquired in noncoding regions by virtue of its larger share of DNA, mutations may occur in exons of genes that contain microsatellite sequences. The type II receptor for TGF beta 1 (TGF beta RII), the insulin-like growth factor II receptor (IGFIIR), and the proapoptotic gene BAX have been shown to contain mononucleotide microsatellites, and in MSI tumors, mutations may occur in these sequences late in the multistep carcinogenesis pathway. Here, we characterize 9 cell lines for MSI and mutations in TGF beta RII, BAX, and IGFIIR by PCR-based assays. The MMR-proficient cell lines SW480 and HT29 demonstrate stability at microsatellite sequences and do not have mutations in TGF beta RII, BAX, or IGFIIR. The MMR-deficient cell lines LoVo, SW48, LS174t, and HCT116 all demonstrate MSI and have only mutant alleles of TGF beta RII. Additionally, SW48 cells were heterozygous for wild-type and mutant IGFIIR. While LoVo and LS174t cells possessed only mutant BAX alleles, HCT116 was heterozygous and SW48 had only the wild-type allele. The MMR-deficient ovarian cell line 2774 demonstrated MSI, but showed only wild-type TGF beta RII, IGFIIR, and BAX alleles. In HCT116+ch2 cells, there was no genotypic change from the hMLH1-mutated HCT116 cells. In HCT116+ch3 cells, MSI was corrected, and this cell line became heterozygous for mutant and wild-type TGF beta RII because wild-type hMLH1 and TGF beta RII are both located on chromosome 3. Thus, the presence of a defective MMR system correlates with MSI, and the wild-type allele of TGF beta RII was absent in all microsatellite unstable colon cell lines, whereas the absence of wild-type BAX occurred in only two colon cell lines. In ovarian cancer cells with MSI, mutations in TGF beta RII, BAX, and IGFIIR may be unimportant in the genesis of this tumor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10757056

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  15 in total

1.  Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate.

Authors:  G W Makin; B M Corfe; G J Griffiths; A Thistlethwaite; J A Hickman; C Dive
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.

Authors:  Xinxin Song; Ashok-Kumar Dilly; Haroon Asif Choudry; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Mol Cancer Res       Date:  2015-09-09       Impact factor: 5.852

3.  HEREDITARY, SPORADIC AND METASTATIC COLORECTAL CANCER ARE COMMONLY DRIVEN BY SPECIFIC SPECTRUMS OF DEFECTIVE DNA MISMATCH REPAIR COMPONENTS.

Authors:  John M Carethers
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 4.  Chemotherapeutic implications in microsatellite unstable colorectal cancer.

Authors:  Won-Seok Jo; John M Carethers
Journal:  Cancer Biomark       Date:  2006       Impact factor: 4.388

5.  Bone morphogenetic protein signaling and growth suppression in colon cancer.

Authors:  Stayce E Beck; Barbara H Jung; Antonio Fiorino; Jessica Gomez; Eunice Del Rosario; Betty L Cabrera; Sherry C Huang; Jimmy Y C Chow; John M Carethers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-07       Impact factor: 4.052

6.  Cellular prion protein contributes to LS 174T colon cancer cell carcinogenesis by increasing invasiveness and resistance against doxorubicin-induced apoptosis.

Authors:  Cornelius Kwang-Lee Chieng; Yee-How Say
Journal:  Tumour Biol       Date:  2015-05-17

7.  Smad4 inactivation promotes malignancy and drug resistance of colon cancer.

Authors:  Panagiotis Papageorgis; Kuanghung Cheng; Sait Ozturk; Yi Gong; Arthur W Lambert; Hamid M Abdolmaleky; Jin-Rong Zhou; Sam Thiagalingam
Journal:  Cancer Res       Date:  2011-01-18       Impact factor: 12.701

8.  Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer.

Authors:  Maide O Raeker; John M Carethers
Journal:  J Cancer Immunol (Wilmington)       Date:  2020

9.  Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.

Authors:  Masakazu Yashiro; Kosei Hirakawa; C Richard Boland
Journal:  BMC Cancer       Date:  2010-06-18       Impact factor: 4.430

10.  Mismatch repair and treatment resistance in ovarian cancer.

Authors:  Jozien Helleman; Iris L van Staveren; Winand N M Dinjens; Patricia F van Kuijk; Kirsten Ritstier; Patricia C Ewing; Maria E L van der Burg; Gerrit Stoter; Els M J J Berns
Journal:  BMC Cancer       Date:  2006-07-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.